Proton Intelligence is developing CKM™, the first wearable, continuous potassium (K+) monitor, designed to support cardiovascular health and improve care for people living with chronic kidney disease (CKD) and diabetes. Potassium imbalances are often asymptomatic yet dangerous, frequently going undetected until hospitalisation or death. CKM™ provides continuous, real-time monitoring beyond clinical settings, addressing a critical gap in routine potassium management.